ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 72 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,796,237 | -39.6% | 1,123,345 | -22.6% | 2.06% | -40.8% |
| Q2 2023 | $11,258,379 | +37.6% | 1,450,822 | +1.0% | 3.48% | +3.1% |
| Q1 2023 | $8,184,887 | +12.4% | 1,435,945 | +16.1% | 3.38% | +62.2% |
| Q4 2022 | $7,281,783 | +88.2% | 1,236,296 | +2.3% | 2.08% | +59.1% |
| Q3 2022 | $3,869,000 | -20.2% | 1,208,992 | +11.7% | 1.31% | -12.3% |
| Q2 2022 | $4,849,000 | – | 1,082,304 | – | 1.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |